Delivery Order SPE2DB20D1109-SPE2DB25FP58R
Award Date 8/15/25
Potential Completion Date 8/18/25
Potential Value $7.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $4,590.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Xifaxan 550 mg, an antibiotic medication commonly used to treat traveler's diarrhea and hepatic encephalopathy. The contract, awarded on September 12, 2025, with an ultimate completion date of September 15, 2025, was competitively awarded with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,968.01 to AmerisourceBergen Drug Corp for 60-count tablets of Xifaxan 550 mg, an antibiotic medication used to treat traveler's diarrhea and certain gastrointestinal conditions. This competitively awarded, firm fixed-price delivery order was issued on September 3, 2025, with an ultimate completion date of September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $11,106.33 to AmerisourceBergen Drug Corp for 60-count tablets of Xifaxan 550 mg, an antibiotic used to treat traveler's diarrhea and certain gastrointestinal conditions. This firm fixed price contract, awarded on August 18, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $36,970.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-tablet supplies of Xifaxan 550 mg, an antibiotic medication used to treat traveler's diarrhea and irritable bowel syndrome. The contract was competitively awarded without set-aside designation and is scheduled for completion by July 21, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,434.78 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Xifaxan is a gastrointestinal antibiotic commonly used to treat traveler's...
- The Defense Logistics Agency awarded a delivery order valued at $25,366.11 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Xifaxan is a non-systemic antibiotic used primarily in the treatment of traveler's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,249.80 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $43,495.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Xifaxan 550 mg tablets (60-count units). The contract, which represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, carries an ultimate completion date of September 4, 2025, and involves no set-aside designation, indicating competitive award status. Performance will be executed at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) with a ceiling value of $20,573.32. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is categorized as a child contract under AmerisourceBergen's broader federal contract portfolio. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Xifaxan 550 mg tablets (60-count units) with a contract value of $4,557.98. This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a non-set-aside, competitively awarded procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...